General Information of DTT (ID: TTOF3WZ)

DTT Name Lipoprotein lipase (LPL) DTT Info
Gene Name LPL

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
2 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clofibrate DMPC1J7 Dysbetalipoproteinemia 5C80.2 Approved [1]
Gemfibrozil DMD8Q3J Hyperlipidaemia 5C80 Approved [2]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AMT-011 DM8QIRN Blood forming organ disorder JB64.1 Phase 3 [3]
Ibrolipim DMOPWSX Hyperlipidaemia 5C80 Phase 2 [4]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
WS-070117 DMYNIG5 Hyperlipidaemia 5C80 Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Effects of clofibrate treatment in laying hens. Poult Sci. 2007 Jun;86(6):1187-95.
2 Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. Drugs Today (Barc). 2006 Jan;42(1):39-64.
3 Alipogene tiparvovec for the treatment of lipoprotein lipase deficiency. Drugs Today (Barc). 2013 Mar;49(3):161-70.
4 NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats. Metabolism. 2005 Dec;54(12):1587-92.